253 results on '"Self, Steve"'
Search Results
2. Correction for Kibler et al., “Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC”
3. Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
4. Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
5. Attitudes of pregnant women toward wearable technology: an observational cross-sectional survey study
6. Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention
7. Time Series Modeling of Pathogen-Specific Disease Probabilities with Subsampled Data
8. A Regression Modeling Approach for Describing Patterns of HIV Genetic Variation
9. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial
10. Whole-genome sequencing of esophageal adenocarcinoma in Chinese patients reveals distinct mutational signatures and genomic alterations
11. Wearable technology for health monitoring during pregnancy: an observational cross-sectional survey study
12. HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders
13. Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
14. Hand, Foot, and Mouth Disease in China: Patterns of Spread and Transmissibility
15. Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gp120 Vaccine
16. Demographic Factors That Influence the Neutralizing Antibody Response in Recipients of Recombinant HIV-1 gpl20 Vaccines
17. Modeling Partially Effective HIV Vaccines in vitro
18. Modeling a Marker of Disease Progression and Onset of Disease
19. Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers
20. Modeling Disease Market Processes in AIDS
21. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape
22. Effect of Different Human Papillomavirus Serological and DNA Criteria on Vaccine Efficacy Estimates
23. Analytic insights into the population level impact of imperfect prophylactic HIV vaccines
24. nCal: an R package for non-linear calibration
25. A transdimensional Bayesian model for pattern recognition in DNA sequences
26. HIV-1 CTL-Based Vaccine Immunogen Selection: Antigen Diversity and Cellular Response Features
27. Identification of Cross-Neutralization Determinants by GAP Analysis: A Mutational Behavior Approach
28. Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC
29. Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines
30. Continuous combined hormone replacement therapy and risk of endometrial cancer
31. VIEWPOINT.
32. Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation
33. Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital
34. Droplet Digital PCR-Based Detection of Clarithromycin Resistance in Helicobacter pylori Isolates Reveals Frequent Heteroresistance
35. The behaviour of the fronts of komatiite lavas in medial to distal settings
36. Joint Report of the Myeloid Section of the Second International Workshop on Human Leukocyte Differentiation Antigens
37. Time Series Modeling of Pathogen-Specific Disease Probabilities with Subsampled Data
38. A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine
39. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses
40. Novel combination shows therapeutic potential against Clostridium difficile infections
41. Low propensity of resistance development of Nisin Miconazole Combination poster ECCMID 2014
42. Time series modeling of pathogen-specific disease probabilities with subsampled data
43. Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy
44. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques
45. Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Tpe 1 Vaccine with or without gpl2O: A Phase 2 Study in Higher- and Lower-Risk Volunteers
46. Bayesian penalized spline models for the analysis of spatio-temporal count data
47. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study
48. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma
49. Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
50. Correction: Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.